Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2-pyridylacetic acid

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AcetatesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Betahistine Treatment in a Cat Model of Vestibular Pathology: Pharmacokinetic and Pharmacodynamic Approaches
This study is a pharmacokinetic (PK) and pharmacodynamics (PD) approach using betahistine doses levels in unilateral vestibular… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2016
2016
Comparative Fasting Bioavailability of 2 Different Betahistine Dihydrochloride 24-mg Tablets: A Single- Dose, Randomized-Sequence, Open-Label, 2-Period Crossover Study in Healthy Thai Volunteers
Objective: To evaluate the bioequivalence of 24 mg betahistine dihydrochloride tablets between the test product (Stei ® ) and the… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
2015
2015
Safety, tolerability and pharmacokinetics of 2‐pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD
Betahistine, a potent histamine H3 receptor antagonist, is being developed for the treatment of attention deficit hyperactivity… Expand
2011
2011
Experimental Kinetics of 2-Pyridylacetic acid Pyrolysis
 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE